Related Experiment Video
Updated: Sep 30, 2026

Testing Animal Anxiety in Rats: Effects of Open Arm Ledges and Closed Arm Wall Transparency in Elevated Plus Maze Test
Published on: June 29, 2018
Immediate effect of intravenous diazepam in neuroleptic-induced acute akathisia: an open-label study
Shigehiro Hirose1, Charles R Ashby
1Fukui Prefectural Hospital, Center of Psychiatry and Neurology, Japan. shigehiro@p2422.nsk.ne.jp
Background:
Neuroleptic-induced akathisia can be severely distressing to some patients. and rapid treatment would be preferable. However, there have been relatively few studies conducted regarding the rapid treatment of akathisia. The effect of intravenous diazepam at the beginning of treatment for akathisia was studied in an open clinical trial.
Method:
The subjects were 18 patients with schizophrenia or bipolar I disorder (DSM-IV criteria) who developed neuroleptic-induced acute akathisia during antipsychotic medication and who required immediate relief from the distress of akathisia. Diazepam was given intravenously to the patients at a rate of 5 mg per 30 seconds.
Results:
All 18 subjects experienced immediate relief from akathisia after the injection of diazepam (mean +/- SD dose = 12.6 +/- 2.6 mg; range, 10-17 mg). They reported no serious adverse effects.
Conclusion:
The results suggest that intravenous diazepam could be used in the treatment of patients with severely distressing akathisia who require immediate relief.
Related Concept Videos
Anxiolytic Drugs: Benzodiazepines and Buspirone
Parenteral Anesthetics: Overview
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Depolarizing Blockers: Pharmocokinetics
